TL;DR: Catena Biosciences is a Y Combinator Summer 2021 startup Using protein coupling to build new therapies, currently active with a team of 7.
Using protein coupling to build new therapies
Last verified:
Catena’s technology lets us attach any two proteins together using an enzyme and the native amino acids tyrosine and cysteine within target proteins. It is a true platform technology because it enables the joining of any two soluble proteins together with minimal engineering and without restrictions due to protein size or complexity. Our work has already been used to modify cancer specific antibodies, CRISPR proteins and even cell surfaces. Our ability to produce modular protein therapeutics in a fraction of the time allows for true library creation across the therapeutics spectrum from oncology, vaccines, inflammatory disease and beyond.
Built by LemStudio
Yes. Catena Biosciences was funded by Y Combinator in the Summer 2021 batch. Using protein coupling to build new therapies
Catena’s technology lets us attach any two proteins together using an enzyme and the native amino acids tyrosine and cysteine within target proteins. It is a true platform technology because it enables the joining of any two soluble proteins together with minimal engineering and without restrictions due to protein siz…
Catena Biosciences was part of Y Combinator's Summer 2021 batch.
Catena Biosciences has a team of 7 people according to Y Combinator's directory.
Catena Biosciences is currently listed as Active with a team of 7 in Y Combinator's directory.
Loading interactive view…